Can Pelvic Radiotherapy Be Omitted in Select Patients With Rectal Cancer?

Lily L. Lai, Clifton D. Fuller, Lisa A. Kachnic, Charles Thomas

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Randomized prospective trials have shown the benefits of adjuvant radiotherapy in decreasing local recurrence rates in stage II and stage III rectal cancer. However, some patients with stage II lesions have relatively low risks of local recurrence when treated with modern surgery alone. This article will discuss important prognostic, diagnostic, and therapeutic factors including depth of tumor invasion, tumor location, improvements in staging with endorectal ultrasound and magnetic resonance imaging, enhanced surgical technique with total mesorectal excision, circumferential tumor margin, and lymph node dissection that may help to better define a subset of stage II rectal cancer patients in which pelvic radiation may be safely omitted.

Original languageEnglish (US)
Pages (from-to)70-74
Number of pages5
JournalSeminars in Oncology
Volume33
Issue numberSUPPL. 11
DOIs
StatePublished - Dec 2006

Fingerprint

Rectal Neoplasms
Radiotherapy
Recurrence
Neoplasms
Adjuvant Radiotherapy
Lymph Node Excision
Magnetic Resonance Imaging
Radiation
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Can Pelvic Radiotherapy Be Omitted in Select Patients With Rectal Cancer? / Lai, Lily L.; Fuller, Clifton D.; Kachnic, Lisa A.; Thomas, Charles.

In: Seminars in Oncology, Vol. 33, No. SUPPL. 11, 12.2006, p. 70-74.

Research output: Contribution to journalArticle

Lai, Lily L. ; Fuller, Clifton D. ; Kachnic, Lisa A. ; Thomas, Charles. / Can Pelvic Radiotherapy Be Omitted in Select Patients With Rectal Cancer?. In: Seminars in Oncology. 2006 ; Vol. 33, No. SUPPL. 11. pp. 70-74.
@article{82d2ea95cfa642d985e87d2bea7be1f3,
title = "Can Pelvic Radiotherapy Be Omitted in Select Patients With Rectal Cancer?",
abstract = "Randomized prospective trials have shown the benefits of adjuvant radiotherapy in decreasing local recurrence rates in stage II and stage III rectal cancer. However, some patients with stage II lesions have relatively low risks of local recurrence when treated with modern surgery alone. This article will discuss important prognostic, diagnostic, and therapeutic factors including depth of tumor invasion, tumor location, improvements in staging with endorectal ultrasound and magnetic resonance imaging, enhanced surgical technique with total mesorectal excision, circumferential tumor margin, and lymph node dissection that may help to better define a subset of stage II rectal cancer patients in which pelvic radiation may be safely omitted.",
author = "Lai, {Lily L.} and Fuller, {Clifton D.} and Kachnic, {Lisa A.} and Charles Thomas",
year = "2006",
month = "12",
doi = "10.1053/j.seminoncol.2006.10.019",
language = "English (US)",
volume = "33",
pages = "70--74",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "SUPPL. 11",

}

TY - JOUR

T1 - Can Pelvic Radiotherapy Be Omitted in Select Patients With Rectal Cancer?

AU - Lai, Lily L.

AU - Fuller, Clifton D.

AU - Kachnic, Lisa A.

AU - Thomas, Charles

PY - 2006/12

Y1 - 2006/12

N2 - Randomized prospective trials have shown the benefits of adjuvant radiotherapy in decreasing local recurrence rates in stage II and stage III rectal cancer. However, some patients with stage II lesions have relatively low risks of local recurrence when treated with modern surgery alone. This article will discuss important prognostic, diagnostic, and therapeutic factors including depth of tumor invasion, tumor location, improvements in staging with endorectal ultrasound and magnetic resonance imaging, enhanced surgical technique with total mesorectal excision, circumferential tumor margin, and lymph node dissection that may help to better define a subset of stage II rectal cancer patients in which pelvic radiation may be safely omitted.

AB - Randomized prospective trials have shown the benefits of adjuvant radiotherapy in decreasing local recurrence rates in stage II and stage III rectal cancer. However, some patients with stage II lesions have relatively low risks of local recurrence when treated with modern surgery alone. This article will discuss important prognostic, diagnostic, and therapeutic factors including depth of tumor invasion, tumor location, improvements in staging with endorectal ultrasound and magnetic resonance imaging, enhanced surgical technique with total mesorectal excision, circumferential tumor margin, and lymph node dissection that may help to better define a subset of stage II rectal cancer patients in which pelvic radiation may be safely omitted.

UR - http://www.scopus.com/inward/record.url?scp=33845381097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845381097&partnerID=8YFLogxK

U2 - 10.1053/j.seminoncol.2006.10.019

DO - 10.1053/j.seminoncol.2006.10.019

M3 - Article

C2 - 17178292

AN - SCOPUS:33845381097

VL - 33

SP - 70

EP - 74

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - SUPPL. 11

ER -